Today: 30 April 2026
Netflix stock falls after hours as Reuters reports possible all-cash Warner Bros bid shift
14 January 2026
1 min read

Netflix stock falls after hours as Reuters reports possible all-cash Warner Bros bid shift

New York, Jan 14, 2026, 16:56 (EST) — After-hours.

Netflix shares slipped about 2% after the bell on Wednesday after a source told Reuters the streamer is preparing an all-cash bid for Warner Bros Discovery’s studios and streaming businesses, replacing an earlier cash-and-stock offer valued at $82.7 billion. The stock traded at $88.55, down $1.79 from Tuesday’s close, after moving between $87.99 and $92.35 during the session.

The possible switch to cash lands at an awkward moment for investors who had been leaning on Netflix’s steady margin story. A bigger cash commitment would put the spotlight back on leverage, funding costs and what the company is willing to pay for scale.

It also turns a deal narrative into a stock narrative. A blockbuster acquisition can change what “good” earnings look like for a few quarters, even if subscribers keep coming in.

The bidding war has been driven by Paramount Skydance’s hostile pursuit of Warner — hostile meaning it is pressing shareholders without the target board’s backing — and Netflix’s push to lock up the studio and streaming crown jewels. Warner’s assets include Warner Bros and HBO, along with franchises such as Harry Potter and DC, and the latest talk is that Netflix wants to make its offer simpler and faster for shareholders to judge.

Some investors are cheering the fight anyway. “We’re pleased with the bidding war here,” Oakmark fund manager Bill Nygren told CNBC on Wednesday, as speculation swirled about whether Netflix will have to put more cash on the table. Investopedia

Netflix’s wobble came in a softer tape. U.S. stocks slipped for a second day as investors digested big-bank earnings and fresh economic data, a backdrop that has made deal headlines a bigger driver of single-stock moves than usual.

For traders, the next question is whether “considering” becomes “filing.” Any formal change to the terms would likely bring new detail on timing and, crucially, how Netflix plans to fund a cash-heavy offer.

A proxy fight — where shareholders are asked to vote on board seats and deal terms — would add another layer of uncertainty. That kind of fight can drag on, and it tends to keep stocks jumpy even when fundamentals are stable.

There is a downside path. If investors decide Netflix is stretching for growth or overpaying for content libraries, the stock can take the hit long before regulators or shareholders make a final call.

The next scheduled catalyst is closer than the lawyers. Netflix said it will post fourth-quarter 2025 results and its business outlook on Tuesday, Jan. 20, 2026 at about 1:01 p.m. Pacific, followed by a live video interview at 1:45 p.m. Pacific, when analysts are likely to press management on the deal’s financing and priorities.

Stock Market Today

  • Why This ASX 200 Biotech Stock Is Under Pressure
    April 30, 2026, 3:23 PM EDT. The ASX 200 biotech sector is facing pressure amid recent market developments. Key factors include regulatory challenges and clinical trial setbacks affecting investor sentiment. This volatility impacts stock valuations and trading volumes, highlighting risks within the biotech industry. Investors are advised to monitor updates carefully and consult financial professionals before making decisions. Recent movements underscore the sector's sensitivity to news flow and operational progress.

Latest article

Rezolve AI Stock Rises After Revenue Tops All of 2025 in 90 Days

Rezolve AI Stock Rises After Revenue Tops All of 2025 in 90 Days

30 April 2026
Rezolve AI reported $60 million in first-quarter revenue, surpassing its audited 2025 total of $46.8 million, based on unaudited accounts. Shares rose 4.9% after the update. The company reaffirmed its $360 million 2026 revenue target and said it can reach profitability without new equity sales. Commerce.com, which rejected Rezolve’s all-stock takeover offer, adopted a poison pill defense.
Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

30 April 2026
Option Care Health shares fell 28% to $19.44 after the company cut its 2026 revenue forecast and reported first-quarter sales of $1.35 billion, missing estimates. The company now expects 2026 revenue of $5.675–$5.775 billion, down from a prior range of $5.8–$6.0 billion, citing pressure in its chronic inflammatory disease portfolio. Adjusted profit guidance was unchanged.
Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

30 April 2026
Stellantis reported a first-quarter net profit of €377 million, reversing a €387 million loss a year earlier, aided by a €400 million expected U.S. tariff refund. Industrial free cash flow remained negative at €1.92 billion. Shares fell 6.4% to €6.22 after the results. CEO Antonio Filosa faces pressure ahead of a May 21 investor day to present a stronger turnaround plan.
Sandisk stock dips after hours as retail rush and $580 Wall Street target keep SNDK in playSandiskSandisk stock dips after hours as retail rush and $580 Wall Street target keep SNDK in play
Previous Story

Sandisk stock dips after hours as retail rush and $580 Wall Street target keep SNDK in playSandiskSandisk stock dips after hours as retail rush and $580 Wall Street target keep SNDK in play

Bank of America stock drops after earnings beat as BAC outlook takes center stage
Next Story

Bank of America stock drops after earnings beat as BAC outlook takes center stage

Go toTop